Global Immunotherapeutic Drugs Market Growth (Status and Outlook) 2022-2028
- LP 4770124
- 100 Pages
- January 2022
- Pharmaceuticals
The United States Immunotherapeutic Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Immunotherapeutic Drugs market, reaching US$ million by the year 2028. As for the Europe Immunotherapeutic Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Immunotherapeutic Drugs players cover Roche, Merck, Novartis, and Johnson & Johnson, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Immunotherapeutic Drugs market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Monoclonal Antibody
Vaccines
Checkpoint Inhibitor
Interferon
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals
Clinics
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Roche
Merck
Novartis
Johnson & Johnson
GlaxoSmithKline
AbbVie
ELI Lilly
Amgen
AstraZeneca
Bristol-Mysers Squibb
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Immunotherapeutic Drugs Market Size 2017-2028
2.1.2 Immunotherapeutic Drugs Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Immunotherapeutic Drugs Segment by Type
2.2.1 Monoclonal Antibody
2.2.2 Vaccines
2.2.3 Checkpoint Inhibitor
2.2.4 Interferon
2.3 Immunotherapeutic Drugs Market Size by Type
2.3.1 Immunotherapeutic Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Immunotherapeutic Drugs Market Size Market Share by Type (2017-2022)
2.4 Immunotherapeutic Drugs Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Other
2.5 Immunotherapeutic Drugs Market Size by Application
2.5.1 Immunotherapeutic Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Immunotherapeutic Drugs Market Size Market Share by Application (2017-2022)
3 Immunotherapeutic Drugs Market Size by Player
3.1 Immunotherapeutic Drugs Market Size Market Share by Players
3.1.1 Global Immunotherapeutic Drugs Revenue by Players (2020-2022)
3.1.2 Global Immunotherapeutic Drugs Revenue Market Share by Players (2020-2022)
3.2 Global Immunotherapeutic Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Immunotherapeutic Drugs by Regions
4.1 Immunotherapeutic Drugs Market Size by Regions (2017-2022)
4.2 Americas Immunotherapeutic Drugs Market Size Growth (2017-2022)
4.3 APAC Immunotherapeutic Drugs Market Size Growth (2017-2022)
4.4 Europe Immunotherapeutic Drugs Market Size Growth (2017-2022)
4.5 Middle East & Africa Immunotherapeutic Drugs Market Size Growth (2017-2022)
5 Americas
5.1 Americas Immunotherapeutic Drugs Market Size by Country (2017-2022)
5.2 Americas Immunotherapeutic Drugs Market Size by Type (2017-2022)
5.3 Americas Immunotherapeutic Drugs Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immunotherapeutic Drugs Market Size by Region (2017-2022)
6.2 APAC Immunotherapeutic Drugs Market Size by Type (2017-2022)
6.3 APAC Immunotherapeutic Drugs Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Immunotherapeutic Drugs by Country (2017-2022)
7.2 Europe Immunotherapeutic Drugs Market Size by Type (2017-2022)
7.3 Europe Immunotherapeutic Drugs Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Immunotherapeutic Drugs by Region (2017-2022)
8.2 Middle East & Africa Immunotherapeutic Drugs Market Size by Type (2017-2022)
8.3 Middle East & Africa Immunotherapeutic Drugs Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Immunotherapeutic Drugs Market Forecast
10.1 Global Immunotherapeutic Drugs Forecast by Regions (2023-2028)
10.1.1 Global Immunotherapeutic Drugs Forecast by Regions (2023-2028)
10.1.2 Americas Immunotherapeutic Drugs Forecast
10.1.3 APAC Immunotherapeutic Drugs Forecast
10.1.4 Europe Immunotherapeutic Drugs Forecast
10.1.5 Middle East & Africa Immunotherapeutic Drugs Forecast
10.2 Americas Immunotherapeutic Drugs Forecast by Country (2023-2028)
10.2.1 United States Immunotherapeutic Drugs Market Forecast
10.2.2 Canada Immunotherapeutic Drugs Market Forecast
10.2.3 Mexico Immunotherapeutic Drugs Market Forecast
10.2.4 Brazil Immunotherapeutic Drugs Market Forecast
10.3 APAC Immunotherapeutic Drugs Forecast by Region (2023-2028)
10.3.1 China Immunotherapeutic Drugs Market Forecast
10.3.2 Japan Immunotherapeutic Drugs Market Forecast
10.3.3 Korea Immunotherapeutic Drugs Market Forecast
10.3.4 Southeast Asia Immunotherapeutic Drugs Market Forecast
10.3.5 India Immunotherapeutic Drugs Market Forecast
10.3.6 Australia Immunotherapeutic Drugs Market Forecast
10.4 Europe Immunotherapeutic Drugs Forecast by Country (2023-2028)
10.4.1 Germany Immunotherapeutic Drugs Market Forecast
10.4.2 France Immunotherapeutic Drugs Market Forecast
10.4.3 UK Immunotherapeutic Drugs Market Forecast
10.4.4 Italy Immunotherapeutic Drugs Market Forecast
10.4.5 Russia Immunotherapeutic Drugs Market Forecast
10.5 Middle East & Africa Immunotherapeutic Drugs Forecast by Region (2023-2028)
10.5.1 Egypt Immunotherapeutic Drugs Market Forecast
10.5.2 South Africa Immunotherapeutic Drugs Market Forecast
10.5.3 Israel Immunotherapeutic Drugs Market Forecast
10.5.4 Turkey Immunotherapeutic Drugs Market Forecast
10.5.5 GCC Countries Immunotherapeutic Drugs Market Forecast
10.6 Global Immunotherapeutic Drugs Forecast by Type (2023-2028)
10.7 Global Immunotherapeutic Drugs Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Immunotherapeutic Drugs Product Offered
11.1.3 Roche Immunotherapeutic Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Immunotherapeutic Drugs Product Offered
11.2.3 Merck Immunotherapeutic Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Merck Main Business Overview
11.2.5 Merck Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Immunotherapeutic Drugs Product Offered
11.3.3 Novartis Immunotherapeutic Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Immunotherapeutic Drugs Product Offered
11.4.3 Johnson & Johnson Immunotherapeutic Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Johnson & Johnson Main Business Overview
11.4.5 Johnson & Johnson Latest Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Information
11.5.2 GlaxoSmithKline Immunotherapeutic Drugs Product Offered
11.5.3 GlaxoSmithKline Immunotherapeutic Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 GlaxoSmithKline Main Business Overview
11.5.5 GlaxoSmithKline Latest Developments
11.6 AbbVie
11.6.1 AbbVie Company Information
11.6.2 AbbVie Immunotherapeutic Drugs Product Offered
11.6.3 AbbVie Immunotherapeutic Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 AbbVie Main Business Overview
11.6.5 AbbVie Latest Developments
11.7 ELI Lilly
11.7.1 ELI Lilly Company Information
11.7.2 ELI Lilly Immunotherapeutic Drugs Product Offered
11.7.3 ELI Lilly Immunotherapeutic Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 ELI Lilly Main Business Overview
11.7.5 ELI Lilly Latest Developments
11.8 Amgen
11.8.1 Amgen Company Information
11.8.2 Amgen Immunotherapeutic Drugs Product Offered
11.8.3 Amgen Immunotherapeutic Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Amgen Main Business Overview
11.8.5 Amgen Latest Developments
11.9 AstraZeneca
11.9.1 AstraZeneca Company Information
11.9.2 AstraZeneca Immunotherapeutic Drugs Product Offered
11.9.3 AstraZeneca Immunotherapeutic Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 AstraZeneca Main Business Overview
11.9.5 AstraZeneca Latest Developments
11.10 Bristol-Mysers Squibb
11.10.1 Bristol-Mysers Squibb Company Information
11.10.2 Bristol-Mysers Squibb Immunotherapeutic Drugs Product Offered
11.10.3 Bristol-Mysers Squibb Immunotherapeutic Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Bristol-Mysers Squibb Main Business Overview
11.10.5 Bristol-Mysers Squibb Latest Developments
12 Research Findings and Conclusion
Table 1. Immunotherapeutic Drugs Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Monoclonal Antibody
Table 3. Major Players of Vaccines
Table 4. Major Players of Checkpoint Inhibitor
Table 5. Major Players of Interferon
Table 6. Immunotherapeutic Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Immunotherapeutic Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Immunotherapeutic Drugs Market Size Market Share by Type (2017-2022)
Table 9. Immunotherapeutic Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Immunotherapeutic Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Immunotherapeutic Drugs Market Size Market Share by Application (2017-2022)
Table 12. Global Immunotherapeutic Drugs Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Immunotherapeutic Drugs Revenue Market Share by Player (2020-2022)
Table 14. Immunotherapeutic Drugs Key Players Head office and Products Offered
Table 15. Immunotherapeutic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Immunotherapeutic Drugs Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Immunotherapeutic Drugs Market Size Market Share by Regions (2017-2022)
Table 20. Americas Immunotherapeutic Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Immunotherapeutic Drugs Market Size Market Share by Country (2017-2022)
Table 22. Americas Immunotherapeutic Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Immunotherapeutic Drugs Market Size Market Share by Type (2017-2022)
Table 24. Americas Immunotherapeutic Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Immunotherapeutic Drugs Market Size Market Share by Application (2017-2022)
Table 26. APAC Immunotherapeutic Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Immunotherapeutic Drugs Market Size Market Share by Region (2017-2022)
Table 28. APAC Immunotherapeutic Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Immunotherapeutic Drugs Market Size Market Share by Type (2017-2022)
Table 30. APAC Immunotherapeutic Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Immunotherapeutic Drugs Market Size Market Share by Application (2017-2022)
Table 32. Europe Immunotherapeutic Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Immunotherapeutic Drugs Market Size Market Share by Country (2017-2022)
Table 34. Europe Immunotherapeutic Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Immunotherapeutic Drugs Market Size Market Share by Type (2017-2022)
Table 36. Europe Immunotherapeutic Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Immunotherapeutic Drugs Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Immunotherapeutic Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Immunotherapeutic Drugs Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Immunotherapeutic Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Immunotherapeutic Drugs Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Immunotherapeutic Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Immunotherapeutic Drugs Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Immunotherapeutic Drugs
Table 45. Key Market Challenges & Risks of Immunotherapeutic Drugs
Table 46. Key Industry Trends of Immunotherapeutic Drugs
Table 47. Global Immunotherapeutic Drugs Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Immunotherapeutic Drugs Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Immunotherapeutic Drugs Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Immunotherapeutic Drugs Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Immunotherapeutic Drugs Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Immunotherapeutic Drugs Market Size Market Share Forecast by Application (2023-2028)
Table 53. Roche Details, Company Type, Immunotherapeutic Drugs Area Served and Its Competitors
Table 54. Roche Immunotherapeutic Drugs Product Offered
Table 55. Roche Immunotherapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Roche Main Business
Table 57. Roche Latest Developments
Table 58. Merck Details, Company Type, Immunotherapeutic Drugs Area Served and Its Competitors
Table 59. Merck Immunotherapeutic Drugs Product Offered
Table 60. Merck Main Business
Table 61. Merck Immunotherapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. Merck Latest Developments
Table 63. Novartis Details, Company Type, Immunotherapeutic Drugs Area Served and Its Competitors
Table 64. Novartis Immunotherapeutic Drugs Product Offered
Table 65. Novartis Main Business
Table 66. Novartis Immunotherapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Novartis Latest Developments
Table 68. Johnson & Johnson Details, Company Type, Immunotherapeutic Drugs Area Served and Its Competitors
Table 69. Johnson & Johnson Immunotherapeutic Drugs Product Offered
Table 70. Johnson & Johnson Main Business
Table 71. Johnson & Johnson Immunotherapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Johnson & Johnson Latest Developments
Table 73. GlaxoSmithKline Details, Company Type, Immunotherapeutic Drugs Area Served and Its Competitors
Table 74. GlaxoSmithKline Immunotherapeutic Drugs Product Offered
Table 75. GlaxoSmithKline Main Business
Table 76. GlaxoSmithKline Immunotherapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. GlaxoSmithKline Latest Developments
Table 78. AbbVie Details, Company Type, Immunotherapeutic Drugs Area Served and Its Competitors
Table 79. AbbVie Immunotherapeutic Drugs Product Offered
Table 80. AbbVie Main Business
Table 81. AbbVie Immunotherapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. AbbVie Latest Developments
Table 83. ELI Lilly Details, Company Type, Immunotherapeutic Drugs Area Served and Its Competitors
Table 84. ELI Lilly Immunotherapeutic Drugs Product Offered
Table 85. ELI Lilly Main Business
Table 86. ELI Lilly Immunotherapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 87. ELI Lilly Latest Developments
Table 88. Amgen Details, Company Type, Immunotherapeutic Drugs Area Served and Its Competitors
Table 89. Amgen Immunotherapeutic Drugs Product Offered
Table 90. Amgen Main Business
Table 91. Amgen Immunotherapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 92. Amgen Latest Developments
Table 93. AstraZeneca Details, Company Type, Immunotherapeutic Drugs Area Served and Its Competitors
Table 94. AstraZeneca Immunotherapeutic Drugs Product Offered
Table 95. AstraZeneca Main Business
Table 96. AstraZeneca Immunotherapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 97. AstraZeneca Latest Developments
Table 98. Bristol-Mysers Squibb Details, Company Type, Immunotherapeutic Drugs Area Served and Its Competitors
Table 99. Bristol-Mysers Squibb Immunotherapeutic Drugs Product Offered
Table 100. Bristol-Mysers Squibb Main Business
Table 101. Bristol-Mysers Squibb Immunotherapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 102. Bristol-Mysers Squibb Latest Developments
List of Figures
Figure 1. Immunotherapeutic Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Immunotherapeutic Drugs Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Immunotherapeutic Drugs Market Size Market Share by Type in 2021
Figure 7. Immunotherapeutic Drugs in Hospitals
Figure 8. Global Immunotherapeutic Drugs Market: Hospitals (2017-2022) & ($ Millions)
Figure 9. Immunotherapeutic Drugs in Clinics
Figure 10. Global Immunotherapeutic Drugs Market: Clinics (2017-2022) & ($ Millions)
Figure 11. Immunotherapeutic Drugs in Other
Figure 12. Global Immunotherapeutic Drugs Market: Other (2017-2022) & ($ Millions)
Figure 13. Global Immunotherapeutic Drugs Market Size Market Share by Application in 2021
Figure 14. Global Immunotherapeutic Drugs Revenue Market Share by Player in 2021
Figure 15. Global Immunotherapeutic Drugs Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Immunotherapeutic Drugs Market Size 2017-2022 ($ Millions)
Figure 17. APAC Immunotherapeutic Drugs Market Size 2017-2022 ($ Millions)
Figure 18. Europe Immunotherapeutic Drugs Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Immunotherapeutic Drugs Market Size 2017-2022 ($ Millions)
Figure 20. Americas Immunotherapeutic Drugs Value Market Share by Country in 2021
Figure 21. Americas Immunotherapeutic Drugs Consumption Market Share by Type in 2021
Figure 22. Americas Immunotherapeutic Drugs Market Size Market Share by Application in 2021
Figure 23. United States Immunotherapeutic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Immunotherapeutic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Immunotherapeutic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Immunotherapeutic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Immunotherapeutic Drugs Market Size Market Share by Region in 2021
Figure 28. APAC Immunotherapeutic Drugs Market Size Market Share by Application in 2021
Figure 29. China Immunotherapeutic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Immunotherapeutic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Immunotherapeutic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Immunotherapeutic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Immunotherapeutic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Immunotherapeutic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Immunotherapeutic Drugs Market Size Market Share by Country in 2021
Figure 36. Europe Immunotherapeutic Drugs Market Size Market Share by Type in 2021
Figure 37. Europe Immunotherapeutic Drugs Market Size Market Share by Application in 2021
Figure 38. Germany Immunotherapeutic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Immunotherapeutic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Immunotherapeutic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Immunotherapeutic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Immunotherapeutic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Immunotherapeutic Drugs Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Immunotherapeutic Drugs Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Immunotherapeutic Drugs Market Size Market Share by Application in 2021
Figure 46. Egypt Immunotherapeutic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Immunotherapeutic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Immunotherapeutic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Immunotherapeutic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Immunotherapeutic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Immunotherapeutic Drugs Market Size 2023-2028 ($ Millions)
Figure 52. APAC Immunotherapeutic Drugs Market Size 2023-2028 ($ Millions)
Figure 53. Europe Immunotherapeutic Drugs Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Immunotherapeutic Drugs Market Size 2023-2028 ($ Millions)
Figure 55. United States Immunotherapeutic Drugs Market Size 2023-2028 ($ Millions)
Figure 56. Canada Immunotherapeutic Drugs Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Immunotherapeutic Drugs Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Immunotherapeutic Drugs Market Size 2023-2028 ($ Millions)
Figure 59. China Immunotherapeutic Drugs Market Size 2023-2028 ($ Millions)
Figure 60. Japan Immunotherapeutic Drugs Market Size 2023-2028 ($ Millions)
Figure 61. Korea Immunotherapeutic Drugs Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Immunotherapeutic Drugs Market Size 2023-2028 ($ Millions)
Figure 63. India Immunotherapeutic Drugs Market Size 2023-2028 ($ Millions)
Figure 64. Australia Immunotherapeutic Drugs Market Size 2023-2028 ($ Millions)
Figure 65. Germany Immunotherapeutic Drugs Market Size 2023-2028 ($ Millions)
Figure 66. France Immunotherapeutic Drugs Market Size 2023-2028 ($ Millions)
Figure 67. UK Immunotherapeutic Drugs Market Size 2023-2028 ($ Millions)
Figure 68. Italy Immunotherapeutic Drugs Market Size 2023-2028 ($ Millions)
Figure 69. Russia Immunotherapeutic Drugs Market Size 2023-2028 ($ Millions)
Figure 70. Spain Immunotherapeutic Drugs Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Immunotherapeutic Drugs Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Immunotherapeutic Drugs Market Size 2023-2028 ($ Millions)
Figure 73. Israel Immunotherapeutic Drugs Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Immunotherapeutic Drugs Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Immunotherapeutic Drugs Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
